GlassScriptPhysician profile
Vivak Patel
NPI 1386069557
$3,908.82
in general payments reported to CMS, 2019-2025
37 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $320 · 2021: $638 · 2022: $440 · 2023: $679 · 2024: $537 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $493.16 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $409.21 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $390.14 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Novartis Pharmaceuticals Corporation | $384.48 | 2020-2025 | |
| Amgen INC. | $376.75 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $213.39 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $179.19 | 2022-2024 | Watchman Flx, Watchman Access System |
| Amarin Pharma, INC. | $175.75 | 2019-2021 | |
| Pfizer INC. | $162.57 | 2022-2025 | |
| Lantheus Medical Imaging, INC. | $118.59 | 2019 | |
| Medtronic Vascular, INC. | $118.02 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.89 | 2021-2025 | Jardiance |
| Esperion Therapeutics, INC. | $99.92 | 2020-2021 | |
| Scpharmaceuticals INC. | $69.85 | 2023-2025 | |
| Vital Connect, INC | $61.30 | 2023-2024 | Vitalpatch Rtm |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.